Innate Pharma S.A. Company Information

Innate Pharma S.A.'s employee growth, exchange listings and data sources


Key Information

  • Name: Innate Pharma S.A.
  • Ticker: IDDA
  • Exchange: MUN
  • Founded: 1999
  • Industry: Biotechnology
  • Sector: Pharmaceuticals & Biotech
  • Market Cap: €211.710m
  • Shares Outstanding: 80.50m
  • Website: https://www.innate-pharma.com

Number of Employees


Location

  • Innate Pharma S.A.
  • 117, Avenue de Luminy
  • BP 30191
  • Marseille
  • Provence-Alpes-Côte d'Azur
  • 13009
  • France


Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
IPHENXTPA (Euronext Paris)YesCategory O Ordinary SharesFREURNov 2006
IDDDB (Deutsche Boerse AG)YesCategory O Ordinary SharesDEEURNov 2006
0EVILSE (London Stock Exchange)YesCategory O Ordinary SharesGBEURNov 2006
IPHY.FOTCPK (Pink Sheets LLC)YesCategory O Ordinary SharesUSUSDNov 2006
IPHPBATS-CHIXE (BATS 'Chi-X Europe')YesCategory O Ordinary SharesGBEURNov 2006
4IPHETLX (Eurotlx)YesCategory O Ordinary SharesITEURNov 2006
IPHANasdaqGS (Nasdaq Global Select)SPON ADS EACH REP 1 ORD SHSUSUSDOct 2019
IDDAMUN (Boerse Muenchen)SPON ADS EACH REP 1 ORD SHSDEEUROct 2019
IDDADB (Deutsche Boerse AG)SPON ADS EACH REP 1 ORD SHSDEEUROct 2019

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2023/09/20 01:24
End of Day Share Price 2023/06/23 00:00
Earnings2023/06/30
Annual Earnings2022/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2023/09/20 01:24
End of Day Share Price 2023/06/23 00:00
Earnings2023/06/30
Annual Earnings2022/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Innate Pharma S.A. is covered by 15 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Olga SmolentsevaBryan Garnier & Co
Yigal NochomovitzCitigroup Inc
Michael Thomas CooperEdison Investment Research